(Q30887632)

27 June 2017

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data (English)

1 reference

27 June 2017

1 reference

1 reference

T Kaiser

1

1 reference

PubMed ID

14727025

27 June 2017

P T Sawicki

series ordinal

2

1 reference

27 June 2017

16 January 2004

1 reference

27 June 2017

1 reference

27 June 2017

47

1 reference

27 June 2017

3

1 reference

27 June 2017

575-580

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-003-1318-y

27 June 2017

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Post-challenge hyperglycaemia is associated with premature death and macrovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Post-load hyperglycaemia-an inappropriate therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Acarbose for type 2 diabetes prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Acarbose for type 2 diabetes prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1318-Y

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14727025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[The "STOP NIDDM" program--can diabetes in the aged be prevented? An international long-term study revisited; does Acarbose delay or prevent the manifestations of type II diabetes]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14727025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14727025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-003-1318-Y

1 reference

PubMed ID

14727025

Dimensions Publication ID

27 June 2017

0 references

1 reference

PubMed ID

14727025